227 related articles for article (PubMed ID: 23313813)
1. A review on current downstream bio-processing technology of vaccine products.
Li M; Qiu YX
Vaccine; 2013 Feb; 31(9):1264-7. PubMed ID: 23313813
[TBL] [Abstract][Full Text] [Related]
2. Vaccine process technology.
Josefsberg JO; Buckland B
Biotechnol Bioeng; 2012 Jun; 109(6):1443-60. PubMed ID: 22407777
[TBL] [Abstract][Full Text] [Related]
3. Process analytical technology (PAT) for biopharmaceutical products.
Rathore AS; Bhambure R; Ghare V
Anal Bioanal Chem; 2010 Sep; 398(1):137-54. PubMed ID: 20480150
[TBL] [Abstract][Full Text] [Related]
4. Single-use disposable technologies for biopharmaceutical manufacturing.
Shukla AA; Gottschalk U
Trends Biotechnol; 2013 Mar; 31(3):147-54. PubMed ID: 23178074
[TBL] [Abstract][Full Text] [Related]
5. Latent variable modeling to assist the implementation of Quality-by-Design paradigms in pharmaceutical development and manufacturing: a review.
Tomba E; Facco P; Bezzo F; Barolo M
Int J Pharm; 2013 Nov; 457(1):283-97. PubMed ID: 24016743
[TBL] [Abstract][Full Text] [Related]
6. Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications.
Read EK; Park JT; Shah RB; Riley BS; Brorson KA; Rathore AS
Biotechnol Bioeng; 2010 Feb; 105(2):276-84. PubMed ID: 19731252
[TBL] [Abstract][Full Text] [Related]
7. Re-processing strategies for biologicals API manufacturing processes.
Opitz U
Dev Biol (Basel); 2003; 113():101-4; discussion 115-6. PubMed ID: 14620858
[TBL] [Abstract][Full Text] [Related]
8. Implementation of QbD for the development of a vaccine candidate.
Haas J; Franklin A; Houser M; Maraldo D; Mikola M; Ortiz R; Sullivan E; Otero JM
Vaccine; 2014 May; 32(24):2927-30. PubMed ID: 24598725
[TBL] [Abstract][Full Text] [Related]
9. Biomanufacturing process analytical technology (PAT) application for downstream processing: Using dissolved oxygen as an indicator of product quality for a protein refolding reaction.
Pizarro SA; Dinges R; Adams R; Sanchez A; Winter C
Biotechnol Bioeng; 2009 Oct; 104(2):340-51. PubMed ID: 19472303
[TBL] [Abstract][Full Text] [Related]
10. System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction.
Singh R; Ierapetritou M; Ramachandran R
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1164-82. PubMed ID: 23523542
[TBL] [Abstract][Full Text] [Related]
11. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).
Aksu B; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; de Matas M; Oostra W; Rantanen J; Weimer M
Eur J Pharm Sci; 2012 Sep; 47(2):402-5. PubMed ID: 22749874
[TBL] [Abstract][Full Text] [Related]
12. Process analytical technology (PAT) for biopharmaceutical products: Part II. Concepts and applications.
Read EK; Shah RB; Riley BS; Park JT; Brorson KA; Rathore AS
Biotechnol Bioeng; 2010 Feb; 105(2):285-95. PubMed ID: 19731253
[TBL] [Abstract][Full Text] [Related]
13. Efficient biological process characterization by definitive-screening designs: the formaldehyde treatment of a therapeutic protein as a case study.
Erler A; de Mas N; Ramsey P; Henderson G
Biotechnol Lett; 2013 Mar; 35(3):323-9. PubMed ID: 23160743
[TBL] [Abstract][Full Text] [Related]
14. Multivariate PAT solutions for biopharmaceutical cultivation: current progress and limitations.
Mercier SM; Diepenbroek B; Wijffels RH; Streefland M
Trends Biotechnol; 2014 Jun; 32(6):329-36. PubMed ID: 24732022
[TBL] [Abstract][Full Text] [Related]
15. Re-processing of biological products: regulatory considerations from the CBER perspective.
Shacter E
Dev Biol (Basel); 2003; 113():105-7; discussion 115-6. PubMed ID: 14620859
[No Abstract] [Full Text] [Related]
16. Roadmap for implementation of quality by design (QbD) for biotechnology products.
Rathore AS
Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883
[TBL] [Abstract][Full Text] [Related]
17. Improved virus purification processes for vaccines and gene therapy.
Nestola P; Peixoto C; Silva RR; Alves PM; Mota JP; Carrondo MJ
Biotechnol Bioeng; 2015 May; 112(5):843-57. PubMed ID: 25677990
[TBL] [Abstract][Full Text] [Related]
18. Advances in downstream processing of biologics - Spectroscopy: An emerging process analytical technology.
Rüdt M; Briskot T; Hubbuch J
J Chromatogr A; 2017 Mar; 1490():2-9. PubMed ID: 27887700
[TBL] [Abstract][Full Text] [Related]
19. Manufacturing of biodrugs: need for harmonization in regulatory standards.
Sahoo N; Choudhury K; Manchikanti P
BioDrugs; 2009; 23(4):217-29. PubMed ID: 19697964
[TBL] [Abstract][Full Text] [Related]
20. A practical approach for exploration and modeling of the design space of a bacterial vaccine cultivation process.
Streefland M; Van Herpen PF; Van de Waterbeemd B; Van der Pol LA; Beuvery EC; Tramper J; Martens DE; Toft M
Biotechnol Bioeng; 2009 Oct; 104(3):492-504. PubMed ID: 19598176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
